NIRAMAI Health Analytix Pvt Ltd

NIRAMAI Health Analytix is an AI-powered medical device company specializing in thermal imaging-based breast cancer screening. Founded in 2016 and headquartered in Bangalore, India, the company develops non-invasive, radiation-free diagnostic solutions for early breast cancer detection. The core technology, Thermalytix, is a computer-aided diagnostic engine combining high-resolution thermal sensing with cloud-hosted machine learning analytics to analyze thermal images and detect breast abnormalities. The platform is clinically validated, backed by 39 patents and 55+ peer-reviewed publications, and has screened 300,000+ women across 200+ hospitals in 22+ countries. NIRAMAI's thermal imaging approach offers significant advantages: it is painless, contactless, privacy-preserving, and operates at 10-20% of the cost of traditional screening methods. The technology is accessible across age groups (18-80+) and is particularly suited for primary care clinics, remote communities, and outreach programs. NIRAMAI SMILE-100, the company's flagship system, received US FDA clearance and CE marking for European markets. The company has received numerous international awards including World Bank Global Women Health Award, National Startup Award, and recognition as a top 100 AI startup globally.